The Feasibility of Dexmedetomidine for Awake Fiberoptic Nasal Intubation

NCT00815893 · clinicaltrials.gov ↗

PHASE2,PHASE3

Phase

UNKNOWN

Status

60

Enrollment

OTHER

Sponsor class

Conditions

Awake Fiberoptic Nasal Intubation

Interventions

DRUG: dexmedetomidine
DRUG: Normal Saline 0.9%
DRUG: propofol 1%

Sponsor

Kaohsiung Medical University Chung-Ho Memorial Hospital